Skip to main content
. 2018 Aug 23;13(8):e0202797. doi: 10.1371/journal.pone.0202797

Fig 5. Effects of RNAi on inflammation markers in vivo.

Fig 5

(A) mRNA expression of MCP-1 in the plaques of the vehicle, scrambled, Lp-PLA2 RNAi, YKL-40 RNAi, and combined Lp-PLA2 and YKL-40 RNAi groups (n = 12); (B) mRNA expression of MMP-8 in the plaques from all groups (n = 12); (C) The concentrations of MCP-1 in the plasma from all groups (n = 24). (D) The concentrations of MMP-8 in the plasma from all groups (n = 24). *P<0.05 vs. vehicle groups; ▲P>0.05 vs. vehicle group; △P<0.05 vs. Lp-PLA2 RNAi and YKL-40 RNAi groups.